Table 3. Prevalence of different comorbidities in the atrial fibrillation population (1,812,620 patients).
Comorbidity | Total population size (count) | Percentage of total patients (%) |
---|---|---|
Congestive Heart Failure | 664,740 | 36.7% |
Cardiomyopathy | 274,680 | 15.2% |
Coronary artery disease | 821,610 | 44.8% |
Hypertension | 1,429,810 | 78.9% |
Anemia of chronic disease | 85,380 | 4.7% |
Chronic kidney disease | 488,460 | 26.9% |
Myocardial infarction | 382,170 | 21.1% |
Chronic obstructive pulmonary disease | 496,630 | 27.4% |
Pulmonary embolism | 97,710 | 5.4% |
Obstructive sleep apnea | 350,180 | 19.3% |
Rheumatoid arthritis | 70,920 | 3.9% |
Hyperthyroidism | 57,920 | 3.2% |
Inflammatory bowel disease | 22,890 | 1.3% |
Alcohol | 64,970 | 3.6% |
Helicobacter pylori infection | 150 | 0.0083% |